Desjardins Clarissa 4
4 · Xenon Pharmaceuticals Inc. · Filed Jan 14, 2020
Insider Transaction Report
Form 4
Desjardins Clarissa
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-01-13+25,000→ 25,000 totalExercise: $16.42Exp: 2030-01-12→ Common Shares (25,000 underlying)
Footnotes (1)
- [F1]One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.